Measuring the benefits of the Reach Up early childhood parenting programme in Jamaica

Not Applicable

Completed

Conditions: Child development and behaviour
Not Applicable

Registration Number: ISRCTN11059214

Lead Sponsor: The University of the West Indies

Brief Summary: 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37125881/ (added 15/04/2024)

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 627

Inclusion Criteria

1. The child is between 5-24 months

At least one of the following:
1. The child referred to the nutrition clinic for under-nutrition
2. Child whose last recorded height-for-age measurement was below -1SD of the WHO reference standards
3. Families where the child or mother is registered with the conditional cash transfer programme (PATH)
4. Mothers who are currently pregnant with a child under 2 years of age
5. Children who live in low socioeconomic environments
6. Adolescent mothers 16-19 years

Exclusion Criteria

1. Child is in Daycare or has no consistent caregiver
2. The baby has a major disability likely to affect their development
3. Mother is aged under 16 years

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current primary outcome measure as of 01/04/2022:1. Child Developmental Quotient (Total Score) is measured using the Griffiths Mental Development Scales- Extended Revised (GMDS-ER) (ARICD, 2006) at the end of the trial.2. Mother/caregiver stimulation in the home (Total Score) measured using an adaptation of the Family Care Indicators questionnaire administered by telephone interview at the end of the trial.Previous primary outcome measure:1. Child Developmental Quotient (Total Score) is measured using the Griffiths Mental Development Scales- Extended Revised (GMDS-ER) (ARICD, 2006) at the end of the trial.2. Mother/caregiver stimulation in the home (Total Score) is measured using the Infant/Toddler HOME questionnaire (Caldwell, 2003) at enrollment and at the end of the trial.

Secondary Outcome Measures